subscribeSubscribe
price-trendAsk Us
Tolero Presents Biomarker Identification Strategies for Invg Agents Alvocidib

Tolero Presents Biomarker Identification Strategies for Invg Agents Alvocidib
PRNEWSWIRE
22 Jun 2020
Share Share
Tolero Pharmaceuticals Presents Findings from Phase 1 Zella 101 Clinical Study

Tolero Pharmaceuticals Presents Findings from Phase 1 Zella 101 Clinical Study
PRNEWSWIRE
12 Jun 2020
Share Share
Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202 Study

Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202 Study
PR NEWSWIRE
15 Jan 2020
Share Share
AbbVie, Tolero team up to test Venclexta combo in AML

AbbVie, Tolero team up to test Venclexta combo in AML
Amirah Al Idrus FIERCE BIOTECH
17 Aug 2018
Share Share
Tolero Pharmaceuticals Receives European Medicines Agency Orphan Drug Designation For Alvocidib For The Treatment Of Acute Myeloid Leukemia

Tolero Pharmaceuticals Receives European Medicines Agency Orphan Drug Designation For Alvocidib For The Treatment Of Acute Myeloid Leukemia
BIOSPACE
26 Feb 2015
Share Share